天祥药业品牌怎么样 申请店铺

我要投票 天祥药业在兽药行业中的票数:45 更新时间:2024-12-27
天祥药业是哪个国家的品牌?「天祥药业」是 新乡天祥药业有限公司 旗下著名品牌。该品牌发源于河南省新乡市,由创始人秦向林在2005-01-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
天祥药业怎么样

新乡天祥药业有限公司是由新乡市兽药研究所与美国Cronell University药学院共同投资1500万建立的集兽药研发、生产、销售、动物保健、科技服务为一体的企业。公司坐落于美丽的新乡市亢村工业园区,占地面积48000平方米,建筑面积22000平方米。公司在引进外资的同时,引进了设备与技术,现有“粉剂/散剂/预混剂、水针剂(含中药提取)、大容量注射液(含中药提取)、口服液(含中药提取)、消毒剂、颗粒剂(含中药提取)”八个剂型车间;饲料线有:饲料添加剂(粉剂、液态)和预混合饲料两条生产线,车间布局合理、设备优良、科技含量高,设计年产量值2亿元。

新乡天祥药业有限公司现有员工200余人,其高级兽医师、教授、副教授10人,中级技术人员68人,大专以上学历占88.6%。公司在技术上依托于美国加州国立大学、美国康奈大学兽医学院、德国国家科学院、中国农大、河南科技学院、郑州牧专各院校。公司注重科技研发。由新乡市兽药研究所挂帅,依托新乡市兽药制剂工程技术研究中心,由专业知识渊博和实践经验丰富的药理学、病理学、药剂学的专家们组成一支实力强大的科研队伍,本着“以产品质量为农户服务,以科学技术为兽医创名”的产品理念。

新乡天祥药业有限公司引进了美国的企业管理理念,拥有一支经验丰富、技术精湛的技术服务团队和高学历、高素质、年轻化的营销团队,现具有完善的营销管理体系,公司现有兽药事业部、禽药事业部、生物科技事业部、天祥兽医院四个销售团队,以优质的产品、新的管理、专业的团队、技术精湛的售后服务团队,使我部的产品畅销在全国各地。

天祥人本着“待人以诚信、人不欺我”“待事以诚信、事无不成”的原则,愿与社会各界朋友携手共进,全心全意专注于动物保健事业的发展。


Xinxiang Tianxiang Pharmaceutical Co., Ltd. is an enterprise invested by Xinxiang Institute of veterinary medicine and cronell University College of pharmacy in the United States with a total investment of 15 million yuan, integrating the R & D, production, sales, animal health care and scientific and technological services of veterinary medicine. The company is located in the beautiful industrial park of Kangcun, Xinxiang City, covering an area of 48000 square meters and a building area of 22000 square meters. At the same time of introducing foreign investment, the company has introduced equipment and technology, and now there are eight dosage forms workshops of "powder / powder / premix, water injection (including Chinese medicine extraction), large volume injection (including Chinese medicine extraction), oral liquid (including Chinese medicine extraction), disinfectant, granule (including Chinese medicine extraction)"; the feed line includes: feed additive (powder, liquid) and premixed feed Production line, reasonable workshop layout, excellent equipment, high technology content, design annual output value of 200 million yuan. Xinxiang Tianxiang Pharmaceutical Co., Ltd. has more than 200 employees, including 10 senior veterinary doctors, professors and associate professors, 68 middle-level technicians, accounting for 88.6% of the total. The company relies on the National University of California, the school of veterinary medicine, the National Academy of Sciences, China Agricultural University, Henan University of science and technology, Zhengzhou pastoral college. The company pays attention to scientific research and development. Under the leadership of Xinxiang Veterinary Medicine Research Institute, relying on Xinxiang veterinary medicine engineering technology research center, a powerful scientific research team is composed of experts with profound professional knowledge and rich practical experience in pharmacology, pathology and pharmaceutics. It is based on the product concept of "serving farmers with product quality and creating famous veterinarians with science and technology". Xinxiang Tianxiang Pharmaceutical Co., Ltd. has introduced the enterprise management concept of the United States. It has an experienced and skilled technical service team and a highly educated, high-quality and young marketing team. Now it has a perfect marketing management system. The company has four sales teams, namely veterinary medicine business department, avian medicine business department, biotechnology business department and Tianxiang veterinary hospital, with high-quality products The new management, professional team and skilled after-sales service team make our products sell well all over the country. Based on the principle of "treating people with integrity, people don't deceive me" and "treating things with integrity, everything can be done", Tianxiang people are willing to work together with friends from all walks of life to focus on the development of animal health care.

本文链接: https://brand.waitui.com/472991d3b.html 联系电话:03734790081

千城特选小程序码

7×24h 快讯

沪上阿姨再次向港交所递交上市申请

36氪获悉,据港交所文件,沪上阿姨(上海)实业股份有限公司再次向港交所提交上市申请书,联席保荐人为中信证券、海通国际、东方证券国际。

2小时前

圣达生物:大股东万健投资拟减持公司不超3%股份

36氪获悉,圣达生物发布公告,公司持股19.14%的大股东天台万健投资发展中心(有限合伙)(简称“万健投资”)拟通过集中竞价、大宗交易方式减持公司股份不超过513.57万股,拟减持比例不超过公司总股本的3%。

2小时前

美股大型科技股盘前多数下跌,特斯拉跌0.52%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,特斯拉跌0.52%,亚马逊跌0.43%,英伟达跌0.38%,奈飞跌0.37%,谷歌跌0.15%,Meta跌0.14%,微软跌0.11%,苹果涨0.12%。

2小时前

热门中概股美股盘前多数下跌,小鹏汽车跌超3%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,小鹏汽车、名创优品跌超3%,京东跌超2%,阿里巴巴、爱奇艺、B站跌超1%,蔚来跌0.43%;理想汽车涨超2%,小马智行涨超1%。

2小时前

央行:实施好适度宽松的货币政策 使社会融资规模、货币供应量增长同经济增长、价格总水平预期目标相匹配

36氪获悉,近日,中国人民银行发布了《中国金融稳定报告(2024)》。其中提到,实施好适度宽松的货币政策,综合运用多种货币政策工具,保持流动性充裕,使社会融资规模、货币供应量增长同经济增长、价格总水平预期目标相匹配。增强外汇市场韧性,稳定市场预期,保持人民币汇率在合理水平上的基本稳定。扩大存款保险基金及其他行业保障基金、金融稳定保障基金资金积累,发挥行业保障基金市场化、法治化处置平台作用,强化存款保险专业化风险处置职能。稳妥有效防范化解重点领域金融风险,牢牢守住不发生系统性金融风险的底线。

2小时前

本页详细列出关于勃林格殷格翰的品牌信息,含品牌所属公司介绍,勃林格殷格翰所处行业的品牌地位及优势。
咨询